A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

U Gatzemeier; B Faderl; H Macha; E Kaukel; K.-M Deppermann; Reiner B. Bonnet; S Hessler

doi:10.1016/S0169-5002(00)80090-2

A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

U Gatzemeier, B Faderl, H Macha, E Kaukel, K.-M Deppermann, Reiner B. Bonnet, S Hessler

Medicine

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Lung Cancer
Volume	29
DOIs	https://doi.org/10.1016/S0169-5002(00)80090-2
State	Published - Sep 1 2000

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1016/S0169-5002(00)80090-2License: Unspecified

OpenUrl availability

Full text

Cite this

@article{19eabf1d4166422d8e5b45fd7e6f15a8,

title = "A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)",

author = "U Gatzemeier and B Faderl and H Macha and E Kaukel and K.-M Deppermann and Bonnet, {Reiner B.} and S Hessler",

year = "2000",

month = sep,

day = "1",

doi = "10.1016/S0169-5002(00)80090-2",

language = "American English",

volume = "29",

journal = "Lung Cancer",

}

TY - JOUR

T1 - A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

AU - Gatzemeier, U

AU - Faderl, B

AU - Macha, H

AU - Kaukel, E

AU - Deppermann, K.-M

AU - Bonnet, Reiner B.

AU - Hessler, S

PY - 2000/9/1

Y1 - 2000/9/1

UR - http://linkinghub.elsevier.com/retrieve/pii/S0169500200800902

U2 - 10.1016/S0169-5002(00)80090-2

DO - 10.1016/S0169-5002(00)80090-2

M3 - Article

VL - 29

JO - Lung Cancer

JF - Lung Cancer

ER -

A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this